Chinese clinical practice guideline on the management of Crohn's disease(2023,Guangzhou)
Crohn's disease(CD)is a complex condition spanning multiple disciplines.Standardized diagnostics and treatment are paramount for enhancing the medical efficacy and improving the prognosis of CD.In recent years,substantial progress has been achieved in both basic and clinical research on CD.The integration of novel diagnostic and therapeutic paradigms,new treatment modalities,have necessitated the update of consensus on CD management,offering imperative,evidence-based guidelines for health providers.This guideline,collaboratively developed by the Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chineses Medical Association,incorporates the latest international consensus,domestic research findings,and practical considerations,as an update based on the 2018 Chinese consensus on diagnosis and treatment in inflammatory bowel disease.The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of CD,providing standardized guidance for the clinical management of CD.
NETL
NSTL
万方数据
